New Results

E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies

Wei Bu Wang, Yu Liang, Yu Qin Jin, Jing Zhang, Ji Guo Su, Qi Ming Li
doi: https://doi.org/10.1101/2021.02.17.431566

Article usage

Article usage: February 2021 to October 2024

AbstractFullPdf
Feb 2021125726269
Mar 2021993109242
Apr 202153078133
May 2021383102145
Jun 20211825163
Jul 20211372336
Aug 20211252238
Sep 20211593445
Oct 2021110848
Nov 2021821036
Dec 2021105312
Jan 202258419
Feb 202236313
Mar 20224085
Apr 20223406
May 202231914
Jun 202224067
Jul 202222658
Aug 20221227
Sep 202223210
Oct 20222724
Nov 20222747
Dec 20221486
Jan 20231834
Feb 20231444
Mar 20231838
Apr 20231033
May 2023834
Jun 20231634
Jul 2023947
Aug 20231536
Sep 20231544
Oct 20237436
Nov 202312625
Dec 20232238
Jan 20241315
Feb 20241536
Mar 2024812
Apr 20241846
May 20241327
Jun 20242144
Jul 202419514
Aug 20241319
Sep 20242526
Oct 2024104
Back to top
Posted February 17, 2021.
Download PDF

Supplementary Material

Email
E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies
Wei Bu Wang, Yu Liang, Yu Qin Jin, Jing Zhang, Ji Guo Su, Qi Ming Li
bioRxiv 2021.02.17.431566; doi: https://doi.org/10.1101/2021.02.17.431566
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area